![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Symbiotica Speciality Ingredients Sdn. Bhd. Perai My, based in Malaysia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Betamethasone dipropionate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-005 - Rev 01
This Chemical Type CEP, issued on December 12, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 809 associated with this CEP further emphasizes